Cancer Research

Innovative Glioblastoma Trial Targets Early Immunotherapy Use
Research & Development Innovative Glioblastoma Trial Targets Early Immunotherapy Use

Glioblastoma is an aggressive form of brain cancer with a median survival rate of just nine months post-diagnosis. This grim statistic raises important questions about the effectiveness of current treatments and the desperate need for new approaches. Consider the journey of many patients, whose

Can Targeting Host Pathways Beat Cryptosporidium?
Research & Development Can Targeting Host Pathways Beat Cryptosporidium?

Cryptosporidium is an intestinal parasite causing severe diarrhea and particularly affects children and those with weakened immune systems, posing significant public health challenges. Efforts to find fully effective treatments have historically faced setbacks due to the organism's adaptability and

Can Roche's Itovebi Transform Breast Cancer Treatment?
Research & Development Can Roche's Itovebi Transform Breast Cancer Treatment?

The approval of Roche’s Itovebi marks a pivotal moment in breast cancer care, with the potential to significantly alter treatment strategies for ER-positive, HER2-negative breast cancer patients with PIK3CA mutations. The regulatory green light indicates a promising shift in oncology, specifically

Universal Cancer Vaccine Breakthrough Boosts Immune System
Research & Development Universal Cancer Vaccine Breakthrough Boosts Immune System

Ivan Kairatov is a renowned Biopharma expert with a wealth of experience in research and development, particularly at the intersection of technology and innovation in the field. Today, he shares insights into the groundbreaking research conducted at the University of Florida on developing a

How Do Evolving Racial Categories Impact Cancer Data Collection?
Research & Development How Do Evolving Racial Categories Impact Cancer Data Collection?

In the rapidly evolving field of cancer epidemiology, understanding how race and ethnicity interact with cancer incidence and mortality is crucial. Ivan Kairatov, a biopharma expert with a strong background in research and development, sheds light on the implications of changing race data

How Does Radiotherapy Reshape Breast Cancer Genomics?
Research & Development How Does Radiotherapy Reshape Breast Cancer Genomics?

Breast cancer remains a formidable adversary in the field of oncology, with radiotherapy serving as one of its most prevalent treatment modalities. Traditionally, radiotherapy is administered postoperatively to eliminate residual cancer cells and reduce the chances of relapse. Yet, the biological

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later